NCT05526248 2026-03-11
ARAMON
Bayer
Phase 2 Completed
Clinical Trials
7 trialsNCT04736199 2026-02-27
ARANOTE
Bayer
Phase 3 Completed
NCT04737109 2023-11-13
ADDItion
Big Ten Cancer Research Consortium
Phase 1/2 Terminated
NCT04157088 2023-08-04
DaroAcT
Bayer
Phase 2 Terminated
NCT02200614 2022-06-28
ARAMIS
Bayer
Phase 3 Completed
NCT01317641 2017-03-29
Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer
Orion Corporation, Orion Pharma
Phase 1/2 Completed
NCT01429064 2017-02-20
Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001
Orion Corporation, Orion Pharma
Phase 2 Completed